[ORGANIZATION]
Rinvoq
Featured in 4 tracked stories · first seen
Situations
AbbVie immunology pipeline and strategic transition
2 clusters · 4 sources · last updated
Latest: AbbVie completes $10.9 billion acquisition of Apogee Therapeutics
AbbVie is undergoing a strategic transition to mitigate the impact of biosimilar competition on its blockbuster drug, Humira. Following a decline in Humira sales to $6.4 billion in 2025, the company has relied on the gro
Rinvoq approval for vitiligo treatment
2 clusters · 3 sources · last updated
Latest: UAE approves first oral medication for vitiligo treatment
The United Arab Emirates has granted approval for the oral use of Rinvoq (upadacitinib) to treat non-segmental vitiligo. This marks the first time the medication has been approved for oral use for this condition globally